Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, July 1, 2024
[ Mon, Jul 01st 2024
] - WOPRAI
[ Mon, Jul 01st 2024
] - WOPRAI
[ Mon, Jul 01st 2024
] - WOPRAI
[ Mon, Jul 01st 2024
] - WOPRAI
[ Mon, Jul 01st 2024
] - WOPRAI
[ Mon, Jul 01st 2024
] - WOPRAI
[ Mon, Jul 01st 2024
] - WOPRAI
[ Mon, Jul 01st 2024
] - WOPRAI
[ Mon, Jul 01st 2024
] - WOPRAI
[ Mon, Jul 01st 2024
] - WOPRAI
[ Mon, Jul 01st 2024
] - WOPRAI
[ Mon, Jul 01st 2024
] - WOPRAI
Fri, June 28, 2024
[ Fri, Jun 28th 2024
] - WOPRAI
[ Fri, Jun 28th 2024
] - WOPRAI
[ Fri, Jun 28th 2024
] - WOPRAI
[ Fri, Jun 28th 2024
] - WOPRAI
[ Fri, Jun 28th 2024
] - WOPRAI
[ Fri, Jun 28th 2024
] - WOPRAI
[ Fri, Jun 28th 2024
] - WOPRAI
[ Fri, Jun 28th 2024
] - WOPRAI
[ Fri, Jun 28th 2024
] - WOPRAI
[ Fri, Jun 28th 2024
] - WOPRAI
[ Fri, Jun 28th 2024
] - WOPRAI
[ Fri, Jun 28th 2024
] - WOPRAI
[ Fri, Jun 28th 2024
] - WOPRAI
[ Fri, Jun 28th 2024
] - WOPRAI
[ Fri, Jun 28th 2024
] - WOPRAI
[ Fri, Jun 28th 2024
] - WOPRAI
Mitchell Kapoor Reiterated (carm) at Strong Buy and Held Target at $8 on, Jun 28th, 2024
Mitchell Kapoor of HC Wainwright & Co., Reiterated "Carisma Therapeutics, Inc." (CARM) at Strong Buy and Held Target at $8 on, Jun 28th, 2024.
Mitchell has made no other calls on CARM in the last 4 months.
There is 1 other peer that has a rating on CARM. Out of the 1 peers that are also analyzing CARM, 0 agree with Mitchell's Rating of Hold.
This is the rating of the analyst that currently disagrees with Mitchell
- Justin Zelin of "BTIG" Initiated at Strong Buy and Held Target at $6 on, Thursday, April 11th, 2024
